Kyverna Therapeutics

KYTX

Market cap $474M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$25

134% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Morgan Stanley Michael Ulz 100% 1-yr KYTX win rate				4 Dec ‘25 11 days ago
Wells Fargo Derek Archila 100% 1-yr KYTX win rate				30 Oct ‘25 1 month ago
HC Wainwright & Co Mitchell Kapoor 100% 1-yr KYTX win rate				27 Oct ‘25 1 month ago